skip to main content

Dabigatran renal decline — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardRenal and Hepatic ImpairmentDabigatran renal declineGPhC CRA

A patient taking dabigatran has worsening chronic kidney disease and new bruising. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: E — Refer for urgent review of anticoagulant dose and renal suitability

Dabigatran is substantially renally cleared and renal decline increases bleeding risk. In this scenario, the pharmacist should prioritise safe supply, appropriate counselling and timely referral or clarification where needed. This is the single best answer because the other options would either delay assessment, ignore a clinically significant risk, or create an unsafe legal or professional outcome.

Reference: BNF